Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by Forestview on Jun 30, 2021 12:05pm

Phase 3 Delay

So, see below for what Dan said.  Though things are opening up after Covid, there is likely a massive backlog...also, Nasdaq uplist is expected to be tied to a Phase 3 start, so eventhough it wasn't mentioned in the news release it's still happening.  Last thing - a CEO update is coming in a couple of weeks...

We will experience a 6-8 week delay due to new Covid-related restrictions in Ontario imposed on Phase 1 clinics in May (we now have to do the study in 3 waves rather than 2). And the FDA itself is behind on it’s timings for meeting. Say another 4 weeks. Putting these together means that we think it’s unlikely we’d get our meeting before Christmas. Tiny stuff, but it’s a retail stock market. We are focused on the big prize: positive Phase III and at the same time, partnering (look at our China Nuance deal). Not sure what you mean by ‘momentum’ – we’re not a promotional agency.
Comment by MasterAlgae on Jun 30, 2021 12:59pm
That Covid delay was expected, hence the long drift down since the $6.00 mark. Let's hope that the Delta variant fades away in USA, Europe and elsewhere - otherwise... What the mkt wants to see is the vote of confidence in H2S, and that Antibe is not going to do Phase III alone. (MasterAlgae won't even go there). That vote of confidence comes from another partnership, North American or ...more  
Comment by Actuarial on Jun 30, 2021 1:21pm
Slightly delay is okay for me. We have already known that PIII will be a successful one - it is only a matter of time. Plus, I am not so eager to retire - working from home is kind of similar to vactaion to me ...... receive pay cheques with the same decent amount but save on time and commute expenses ...... it is okay for me ...... I have enough patient to wait for my big prize from ATE.
Comment by MrMugsy on Jun 30, 2021 4:45pm
That's the thing ... Patience and Thick Skin - gets you through everytime. Unless bankruptcy sneaks up on you ... and we know that can't happen with mega-mulla in the bank !!!  Hahaha !!! Oh ya ... we've also got a lung inflammation drug in the works (covid related). The further we go - the further along that product develops.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities